Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Lytic-peptide-Her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use

Lytic-peptide-Her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use

US Patent 9586996 · Granted Mar 7, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for diagnosing LHRH or hCG/LH receptor expressing tumors, cancers and ne2021
Methods for diagnosing LHRH or hCG/LH receptor expressing tumors, cancers and ne2021
Lytic-peptide-Her2/neu (Human Epidermal growth factor Receptor 2) ligand conjuga2020
Lytic-peptide-Her2/neu (Human Epidermal growth factor Receptor 2) ligand conjuga2020
Antibody/drug conjugates and methods of use2019
Antibody/drug conjugates and methods of use2019
Methods for diagnosis of and predicting treatment efficacy of hormone receptor e2018
Methods for diagnosis of and predicting treatment efficacy of hormone receptor e2018
Antibody/drug conjugates and methods of use2016
Antibody/drug conjugates and methods of use2016
Lytic domain fusion constructs and methods of making and using same2016
Lytic domain fusion constructs and methods of making and using same2016